|
Post by letitride on Apr 5, 2019 20:51:34 GMT -5
Ohhhhhhhhhhhhh this is so Fing easy I would start by thanking Mike for taking the job and putting Mannkind back together again. Followed by if there is anything you need we are at your beck and call go out there and get it done.
|
|
|
Post by sportsrancho on Apr 5, 2019 20:55:33 GMT -5
Lol! If only you could take the place of all the board members they’re probably arguing about everything! If only I were a fly on the wall of the Mannkind BOD 🤣
|
|
|
Post by wsulylecoug on Apr 5, 2019 21:15:52 GMT -5
I can’t imagine a harder job than the reps have. And I certainly don’t blame Mike for being optimistic about his guidance. But the model doesn’t work, they are strangled by the label, they can’t educate the doctors about the correct way to dose or to use Afrezza to get the optimum results. And 10 minutes with your Endo every two months doesn’t cut it. That’s why the reps try to find the patients Afrezza buddies. The more the “Afrezza village” builds the better it will get. But as sayhey says clinics are the best protocol. IMO Also I wouldn’t mind seeing them co/partnering with SENS, ( CGM ) And have twice as many reps. Laura could even be the face for both:-) The partnership with SENS and somehow incorporating VDEX is the Bermuda Triangle for the status quo. SENS is battling the CGM big dogs with technology they wish they all had, VDEX is providing results with Afrezza that would keep diabetics healthy and living longer complication free. Throw in Vascepa for good measure and lots of PCP’s will be bored.
|
|
|
Post by mango on Apr 5, 2019 21:17:07 GMT -5
A vote for me is a voice for thee. (😎)
|
|
|
Post by mytakeonit on Apr 6, 2019 1:54:46 GMT -5
I hope Mango can suck seed.
|
|
|
Post by akemp3000 on Apr 6, 2019 6:52:39 GMT -5
IMO, when Mike overhauled the previous business plan to put new attention towards the pipeline and international possibilities, he and the BODs most likely began by looking at the entire world map. Consider that his prior position was V.P. Global Commercial Lead at Amgen and Dr. Kendall was V.P. of Global Medical Affairs for Eli Lilly Diabetes. The first thing they probably did was to discuss the potential of every country along with the variables that would be attached to each. This would include product potential, revenue potential and the challenge of entering and succeeding in each country.
This would not be rocket science for someone that earned a Master's degree from Wharton. While the choice of countries and slower uptake than we'd like to see can of course be debated in hindsight, to think Mike and the BODs did not consider all countries is not likely. Again IMO, the plan just needs to continue forward and play out. I believe Mike said the turnaround would take about three years and we're just now approaching the end of year two since he began as CEO. My bet is that his report card at the end of year three will be impressive. GL
|
|
|
Post by golfeveryday on Apr 6, 2019 8:17:26 GMT -5
I can’t imagine a harder job than the reps have. And I certainly don’t blame Mike for being optimistic about his guidance. But the model doesn’t work, they are strangled by the label, they can’t educate the doctors about the correct way to dose or to use Afrezza to get the optimum results. And 10 minutes with your Endo every two months doesn’t cut it. That’s why the reps try to find the patients Afrezza buddies. The more the “Afrezza village” builds the better it will get. But as sayhey says clinics are the best protocol. IMO Also I wouldn’t mind seeing them co/partnering with SENS, ( CGM ) And have twice as many reps. Laura could even be the face for both:-) when I worked as a rep selling insulin in the transition from vial to pen cartridges, we did switch clinics at pharmacies. We would bring in a Diabetes Educator and advertise the day. Patients would sign up for 30-45 minute appointments and be walked through the convenience of a pen vs vial and syringe. They would walk away with a new insulin pen, insulin, and needles for free. It worked extremely well. The pharmacists would then become very familiar with the product as well. Picture 70 reps simply conducting 5 of these clinics this year. That’s 350 clinics and maybe 5-10 patients switched per clinic. The math can be done however one wants but these numbers are realistic and have an impact. Not sure if they would be allowed to do this type of thing. Just mentioning it has been done before. At the time, I also recall the BGM companies doing something very similar and giving away the monitors at pharmacies.
|
|
|
Post by prcgorman2 on Apr 6, 2019 8:38:09 GMT -5
I can’t imagine a harder job than the reps have. And I certainly don’t blame Mike for being optimistic about his guidance. But the model doesn’t work, they are strangled by the label, they can’t educate the doctors about the correct way to dose or to use Afrezza to get the optimum results. And 10 minutes with your Endo every two months doesn’t cut it. That’s why the reps try to find the patients Afrezza buddies. The more the “Afrezza village” builds the better it will get. But as sayhey says clinics are the best protocol. IMO Also I wouldn’t mind seeing them co/partnering with SENS, ( CGM ) And have twice as many reps. Laura could even be the face for both:-) At the risk of inviting misinformation I’m going to ask a question about what a sales rep who is also a PWD can say. (Maybe that will be me someday?) When reviewing the label and instructions to take Afrezza “at the beginning of a meal”, can a rep say, “I take mine a few minutes after starting my meal.”? I’ve no idea how common the practice is of taking Afrezza a few minutes into a meal versus at the beginning, but I’ve noticed this is one of the points of discussion regarding dose administration. Just curious what latitude a sales rep who is also a patient has in describing their personal experience. Perhaps has to caveat with the comment, “I am prevented from misrepresenting dose administration. People who take Afrezza should follow the FDA’s instructions. Diabetics have to treat themselves, so naturally they may experiment and find that for their personal experience TCOYD means taking the dose a little later. I personally take my Afrezza a little later”. My guess is that’s a no-go, but just curious.
|
|
|
Post by prcgorman2 on Apr 6, 2019 8:42:29 GMT -5
I can’t imagine a harder job than the reps have. And I certainly don’t blame Mike for being optimistic about his guidance. But the model doesn’t work, they are strangled by the label, they can’t educate the doctors about the correct way to dose or to use Afrezza to get the optimum results. And 10 minutes with your Endo every two months doesn’t cut it. That’s why the reps try to find the patients Afrezza buddies. The more the “Afrezza village” builds the better it will get. But as sayhey says clinics are the best protocol. IMO Also I wouldn’t mind seeing them co/partnering with SENS, ( CGM ) And have twice as many reps. Laura could even be the face for both:-) when I worked as a rep selling insulin in the transition from vial to pen cartridges, we did switch clinics at pharmacies. We would bring in a Diabetes Educator and advertise the day. Patients would sign up for 30-45 minute appointments and be walked through the convenience of a pen vs vial and syringe. They would walk away with a new insulin pen, insulin, and needles for free. It worked extremely well. The pharmacists would then become very familiar with the product as well. Picture 70 reps simply conducting 5 of these clinics this year. That’s 350 clinics and maybe 5-10 patients switched per clinic. The math can be done however one wants but these numbers are realistic and have an impact. Not sure if they would be allowed to do this type of thing. Just mentioning it has been done before. At the time, I also recall the BGM companies doing something very similar and giving away the monitors at pharmacies. Simple, effective, and therefore BRILLIANT!! Best post of the day so far.
|
|
|
Post by letitride on Apr 6, 2019 11:44:22 GMT -5
I always believed the best Rep for Afrezza would be a Typ 1 with a CGM, out out for an evening of dinning with the doctor or doctors to be presented to. A kind of fine dinning in your face presentation, no explanations needed.
|
|
|
Post by radgray68 on Apr 6, 2019 12:25:41 GMT -5
First question would be: As a board member, what's the maximum number of shares I can own?
All kidding aside, I believe Locust Walk (locust pond?something?) Already did the type of global market potential survey you're talking about.
|
|
|
Post by BlueCat on Apr 6, 2019 12:31:05 GMT -5
"Hurry up - where's that 10x return?"
That said - according to the chart - regardless of 'script' count (which is apples/oranges anyway since start), looks like this last week was the highest revenue week on record.
But they gotta find that 'hockey stick moment' ..... better isn't necessarily good.
|
|
|
Post by letitride on Apr 6, 2019 12:43:25 GMT -5
From what I can see were all on the board proboards that is. And of the same affect as the Mankind board its whos running the show that counts. I laugh every time I think Apples board tossed Steve Jobs.
|
|